NAVCO Pharmaceuticals Inc
Toronto Stock Exchange VenturesTotal Valuation
NAVCO Pharmaceuticals Inc carries a market capitalization of 285,348.00, placing it among publicly traded companies globally.
| Market Cap | 285,348.00 |
| Enterprise Value | N/A |
Share Statistics
NAVCO Pharmaceuticals Inc currently has 4.60M shares outstanding.
| Shares Outstanding | 4.60M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 118.74 |
| P/TBV Ratio | 118.74 |
| P/FCF Ratio | -11.63 |
| P/OCF Ratio | -11.63 |
Financial Position
NAVCO Pharmaceuticals Inc maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.04 |
| Quick Ratio | 1.04 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -171.68 |
| Return on Assets (ROA) | -45.68 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
NAVCO Pharmaceuticals Inc's stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -52,988.00, while operating income came in at -52,988.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -52,988.00 |
| Pretax Income | -46,978.00 |
| Net Income | -46,978.00 |
| EBITDA | -52,988.00 |
| EBIT | -52,988.00 |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
Total book value stands at 3,874.00, with working capital of 3,874.00 providing operational flexibility.
| Cash & Cash Equivalents | N/A |
| Total Debt | N/A |
| Net Debt | 155.00 |
| Equity (Book Value) | 3,874.00 |
| Book Value Per Share | 0.00 |
| Working Capital | 3,874.00 |
Cash Flow
NAVCO Pharmaceuticals Inc produced -22,361.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -22,361.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -22,361.00 |
| FCF Per Share | -0.01 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -4.35 |
| FCF Yield | -8.60 |
Scores
NAVCO Pharmaceuticals Inc posts an Altman Z-Score of -4.69, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -4.69 |